The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets

Cannabidiol (CBD), the major nonpsychoactive Cannabis constituent, has been proposed for the treatment of a wide panel of neurological and neuropsychiatric disorders, including anxiety, schizophrenia, epilepsy and drug addiction due to the ability of its versatile scaffold to interact with diverse m...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, Rosa Maria, Iannotti, Fabio Arturo, Amodeo, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124847/
https://www.ncbi.nlm.nih.gov/pubmed/34062987
http://dx.doi.org/10.3390/ijms22094876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124847/
https://www.ncbi.nlm.nih.gov/pubmed/34062987
http://dx.doi.org/10.3390/ijms22094876

Ejemplares similares